Trials / Conditions / Childhood Solid Tumor

Childhood Solid Tumor

13 registered clinical trials studyying Childhood Solid Tumor — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer NCT06208657	Australian & New Zealand Children's Haematology/Oncology Group	Phase 1 / Phase 2
Recruiting	Precision Medicine for Every Child With Cancer NCT05504772	Australian & New Zealand Children's Haematology/Oncology Group	—
Active Not Recruiting	Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors NCT03585465	Centre Oscar Lambret	Phase 1 / Phase 2
Completed	Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and You NCT03445858	Children's Hospital Medical Center, Cincinnati	EARLY_Phase 1
Completed	Comparing the Impact of Cancer on Quality of Life Between Survivors of Childhood Solid Tumors and Leukemia NCT03430752	The University of Hong Kong	—
Active Not Recruiting	PRecISion Medicine for Children With Cancer NCT03336931	Sydney Children's Hospitals Network	—
Completed	COZMOS:Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain/Sol NCT03206021	The Hospital for Sick Children	Phase 1
Terminated	Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) NCT02624388	University of Virginia	Phase 2
Completed	Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors NCT01670175	University of California, San Francisco	Phase 1
Recruiting	French Childhood Cancer Survivor Study NCT01620372	Institut National de la Santé Et de la Recherche Médicale, France	—
Terminated	Haploidentical Stem Cell Transplantation and IL-15 NK Cell Infusion for Paediatric Refractory Solid Tumours NCT01337544	Hospital Infantil Universitario Niño Jesús, Madrid, Spain	Phase 1 / Phase 2
Unknown	Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells NCT01919866	University Children's Hospital Tuebingen	Phase 1 / Phase 2
Completed	Cancer Immune Therapy for the Treatment of Refractory Solid Tumours of Childhood NCT02533895	Activartis Biotech	Phase 1